Deficient interleukin-2-activated killer cell cytotoxicity in patients with systemic lupus erythematosus

This publication has 24 references indexed in Scilit:

• Age-associated alterations in human natural killer cells
  Clinical Immunology and Immunopathology, 1987
• The IL-2 Receptor β Chain (p70): Role in Mediating Signals for LAK, NK, and Proliferative Activities
  Science, 1987
• Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.
  The Journal of Experimental Medicine, 1986
• THE DIFFERENTIAL INHIBITORY EFFECTS EXERTED BY CYCLOSPORINE AND HYDROCORTISONE ON THE ACTIVATION OF HUMAN CYTOTOXIC LYMPHOCYTES BY RECOMBINANT INTERLEUKIN-2 VERSUS ALLOSPECIFIC CTL
  Transplantation, 1985
• Interleukin-2 restores the depressed allogeneic cell-mediated lympholysis and natural killer cell activity in patients with systemic lupus erythematosus
  Clinical Immunology and Immunopathology, 1985
• Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells.
  Journal of Clinical Investigation, 1985
• Abnormalities in autologous mixed lymphocyte reaction‐activated immunologic processes in systemic lupus erythematosus and their possible correction by interleukin 2
  European Journal of Immunology, 1985
• Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
  The Journal of Experimental Medicine, 1982
• Natural killer function in systemic lupus erythematosus
  Arthritis & Rheumatism, 1980
• Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases.
  Journal of Clinical Investigation, 1976